Scinovex
review Open AccessTop 1% cited

Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics

Journal of Clinical Medicine · 2020 · Vol. 9(4) · pp. 1061–1061
Mehdi Sharifi‐RadChintha LankatillakeDaniel A. DiasAnca Oana DoceaMohamad Fawzi MahomoodallyDevina LobinePaul L. ChazotBegum KurtTugba Boyunegmez TumerAna Catarina MoreiraFarukh SharopovMiquel MartorellNatália MartinsWilliam C. ChoDaniela CălinaJavad Sharifi‐Rad

Abstract

Among the major neurodegenerative disorders (NDDs), Alzheimer's disease (AD) and Parkinson's disease (PD), are a huge socioeconomic burden. Over many centuries, people have sought a cure for NDDs from the natural herbals. Many medicinal plants and their secondary metabolites are reported with the ability to alleviate the symptoms of NDDs. The major mechanisms identified, through which phytochemicals exert their neuroprotective effects and potential maintenance of neurological health in ageing, include antioxidant, anti-inflammatory, antithrombotic, antiapoptotic, acetylcholinesterase and monoamine oxidase inhibition and neurotrophic activities. This article review the mechanisms of action of some of the major herbal products with potential in the treatment of NDDs according to their molecular targets, as well as their regional sources (Asia, America and Africa). A number of studies demonstrated the beneficial properties of plant extracts or their bioactive compounds against NDDs. Herbal products may potentially offer new treatment options for patients with NDDs, which is a cheaper and culturally suitable alternative to conventional therapies for millions of people in the world with age-related NDDs.

Cholinesterase and Neurodegenerative DiseasesMedicinal Plants and NeuroprotectionMedicinal Plants and Bioactive CompoundsMedicineNeuroprotectionDiseaseAntithromboticNeurosciencePharmacologyPsychiatryInternal medicineBiology

Funding

  • Fundação para a Ciência e a Tecnologia
  • Comisión Nacional de Investigación Científica y Tecnológica
Citations
242
FWCI
24.64
field-weighted impact
References
122
Percentile
100%
vs. same field & year
Citations per year
References
α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
American Journal Of Pathology · 2000 · 708 citations
Oxidative stress in Parkinson's disease
Annals of Neurology · 2003 · 2,042 citations
The cholinergic hypothesis of Alzheimer's disease: a review of progress
Journal of Neurology Neurosurgery & Psychiatry · 1999 · 2,161 citations
Natural Products as Sources of New Drugs from 1981 to 2014
Journal of Natural Products · 2016 · 5,787 citations
Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
Frontiers in Pharmacology · 2016 · 421 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.